Cucurbitacin I appears to be a potent inhibitor in meningioma cells and effective at concentrations similar to that effective on nasopharyngeal carcinoma cells [30] and lower than effective on ALK-positive anaplastic large cell lymphoma cells [32] and pancreatic carcinoma cells [29]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.